Scarica l'app Stockscreener
1.35
0.74%
-0.01
Dopo l'orario di chiusura:
1.33
-0.02
-1.48%
Precedente Chiudi:
$1.36
Aprire:
$1.38
Volume 24 ore:
651.98K
Relative Volume:
0.95
Capitalizzazione di mercato:
$49.99M
Reddito:
-
Utile/perdita netta:
$-25.94M
Rapporto P/E:
-0.9783
EPS:
-1.38
Flusso di cassa netto:
$-15.79M
1 W Prestazione:
+9.76%
1M Prestazione:
+29.81%
6M Prestazione:
-21.51%
1 anno Prestazione:
-32.50%
Intervallo 1D:
$1.25
$1.42
Intervallo di 1 settimana:
$1.25
$1.75
Portata 52W:
$0.87
$2.74
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Nome
MAIA Biotechnology Inc
Settore
Industria
Telefono
312 416 8592
Indirizzo
444 West Lake Street, Suite 1700, Chicago
Confronta MAIA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.35 | 50.36M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
MAIA Biotechnology Inc Borsa (MAIA) Ultime notizie
MAIA Biotechnology Announces Significant Insider Buying - TipRanks
MAIA Biotechnology, Inc. Announces Key Developments in Cancer Therapy - TradingView — Track All Markets
MAIA Biotechnology (NYSE American: MAIA) begins Phase 3 NSCLC study of telomere-targeting ateganosine - Stock Titan
MAIA Biotechnology (MAIA) doses first patient in THIO-104 Phase 3 NSCLC trial - Stock Titan
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential - GlobeNewswire
MAIA Biotechnology announces significant insider buying - MSN
MAIA Biotechnology Advances NSCLC Treatment with Ateganosine - TipRanks
MAIA Biotechnology, Inc. Targets $50B Immunotherapy Market with New Approach - TradingView — Track All Markets
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach - The Manila Times
MAIA Biotechnology (NYSE American: MAIA) starts Phase 3 telomere drug trial in NSCLC - Stock Titan
Prepare Yourself for Liftoff: MAIA Biotechnology Inc (MAIA) - setenews.com
Director Makes Bold Move with Major Stock Purchase in MAIA Biotechnology! - TipRanks
Can MAIA Biotechnology Inc. stock sustain revenue momentum2025 Price Targets & Real-Time Price Movement Reports - Newser
How MAIA Biotechnology Inc. stock reacts to bond yieldsWeekly Gains Summary & Free Technical Pattern Based Buy Signals - Newser
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock By Investing.com - Investing.com Australia
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock - Investing.com
Is MAIA Biotechnology Inc. stock among top earnings plays2025 Stock Rankings & Daily Chart Pattern Signals - Newser
How MAIA Biotechnology Inc. stock compares with top peersMarket Trend Summary & Fast Gain Swing Alerts - Newser
Why hedge funds are buying MAIA Biotechnology Inc. stockRisk Management & Daily Risk Controlled Trade Plans - Newser
MAIA Biotechnology Inc (MAIA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com
How MAIA Biotechnology Inc. stock responds to policy changesTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Will MAIA Biotechnology Inc. stock return to pre crash levels2025 Bull vs Bear & Smart Allocation Stock Reports - Newser
How MAIA Biotechnology Inc. stock compares with market leaders2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Will MAIA Biotechnology Inc. stock recover faster than industryAnalyst Upgrade & Safe Entry Zone Tips - Newser
Why MAIA Biotechnology Inc. stock could rally stronglyJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser
Top Executives Make Bold Moves with Major Stock Purchases at MAIA Biotechnology! - TipRanks
Maia Biotechnology announces open market purchases by CEO and directors - marketscreener.com
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors - The Manila Times
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 By Investing.com - Investing.com Australia
Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares By Investing.com - Investing.com South Africa
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares By Investing.com - Investing.com South Africa
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 - Investing.com India
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares - Investing.com
MAIA Biotechnology Executives Increase Holdings - TradingView — Track All Markets
Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares - Investing.com
MAIA Biotechnology Inc Stock Analysis and ForecastMACD Histogram Signals & Affordable Market Trading - earlytimes.in
CEO’s Bold Move: Major Stock Purchase at MAIA Biotechnology! - TipRanks
MAIA Biotechnology Inc Azioni (MAIA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Capitalizzazione:
|
Volume (24 ore):